BREAKING: Trump Administration Cuts Funding to Pediatric Brain Cancer Research National Cancer Institute ends funding for pediatric brain tumor consortium.

The PBTC, first established in 1999, has led dozens of critical early-phase clinical trials. Its dissolution represents the loss of a dedicated network for pediatric brain cancer research at a time when brain tumors are the leading cause of cancer-related death in children.

NCI officials say that future trials will be shifted to the Children’s Oncology Group’s Pediatric Early Phase Clinical Trials Network (PEP-CTN), which oversees a broader range of pediatric cancers. The administration insists there will not be an immediate funding gap. But pediatric oncologists warn that folding brain tumor research into a broader framework risks diluting focus and slowing progress in a field where specialized infrastructure and expertise are essential.

This move comes against the backdrop of broader Trump administration cuts to NIH and medical research programs, which researchers and advocates say are undermining the nation’s scientific leadership.

Why in the hell would a U.S. President cut off cancer research funding for adults, much less for pediatric brain cancer research?

The answer can be found in one of Trump's billionaire buddies who tell him that traditional cancer research is a relic of the past and the new path is AI medical solutions.

Coincidentally AI medical solutions from his billionaire buddies.

Of course that's bullshit for a few reasons, including the fact that traditional cancer research institutes do employ AI modeling in their cancer research.

Of course Donald Trump is a complete and total moron and has no business whatsoever cutting off federal cancer research funding, yet he still won't federalize cannabis.

What a perfect jackass.

No one has ever seen anything like it before.

They tell me it's one of a kind.

There's never been such a perfect lying ass.

The Trump administration has moved to end funding for the Pediatric Brain Tumor Consortium (PBTC), a 26-year-old clinical trial network that has been central to research on treatments for pediatric brain cancers.

The National Cancer Institute (NCI) confirmed the decision last week, sparking alarm among doctors and patient advocates.